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Abstract 
Background:  Skin cancer is an increasing worldwide public health concern.  
Rates of melanoma and skin cancer continue to rise worldwide, creating a significant 
public health need for detection.  In 2003, nearly 54,000 Americans were diagnosed with 
melanoma with an expected 7,700 deaths.  The visual skin exam is an effective secondary 
prevention tool in detecting melanoma and nonmelanoma skin cancer and may be 
implemented in occupational medical clinics.   
Methods: Applying the results of a comprehensive literature review of skin cancer 
screening efforts in communities and workplaces to occupational medicine.  
Results:  Skin cancer screening efforts have identified high-risk populations for 
melanoma and nonmelanoma skin cancer and may detect suspicious lesions early. 
Conclusions: Occupational physicians may be the only healthcare provider with the 
opportunity to screen a high-risk population, particularly males over age 50.  Integrating 
a skin examination into pre-employment or periodic examinations would expend minimal 
time and funds while potentially preventing worker morbidity and mortality.  Screening 
for skin cancer at the workplace may also fulfill a public health need.  The integration of 
skin cancer screening into occupational medicine may simultaneously improve worker 
health and increase the value of the occupational medicine physician. 
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 INTRODUCTION 
 
 
 
 
Worldwide, skin cancer is an increasing public health concern (Koh, 1991).  Estimates of 
skin cancer affecting Americans exceed 1 million per year, surpassing all other types of 
cancer combined (Wingo et al., 1998).  About 54,000 Americans were estimated to be 
diagnosed with melanoma, with an expected 7,700 deaths (CDC, 2003).  A child born in 
the year 2000 has an estimated lifetime risk of melanoma of 1 in 75 (Rigel, 1996).  The 
estimated lifetime risk of developing skin cancer of any kind was estimated to be 1 in 5 in 
1997 (Rigel et al., 1996).   
A collaborative effort between the U.S. Preventive Services Task Force, 
supported by the Agency for Healthcare Research and Quality and the Task Force on 
Community Preventive Services, supported by the CDC, provides guidelines of worksite 
(as well as community) interventions to promote health and prevent disease (CDC, 2003).  
While the primary prevention of skin cancer has been attempted by both public education 
campaigns (ultraviolet radiation) and governmental occupational and environmental 
health regulations (specific substance exposures), there remains a large disparity between 
the public’s knowledge and action, particularly with regard to sun behavior.   
Although primary prevention of skin cancer is of great concern, skin cancer 
screening is an important modality of secondary prevention.  Early detection of 
melanoma should increase cure rates; localized melanoma long-term survival rates of 
92% contrast with less than 5% long-term survival rate for metastatic melanoma (Miller 
et al., 1993).  Nonmelanoma skin cancer (NMSC), although infrequently fatal, can cause 
local, extensive tissue destruction (Koh et al., 1989).  An effective combination of 
primary and secondary preventative measures should decrease both the morbidity and 
mortality of melanoma and NMSC (Koh et al., 1996).  The implementation of 
dermatologic screening in the workplace will be explored, with emphasis on past studies 
of screening endeavors and future possibilities with regards to secondary prevention of 
skin cancer and the proposed role of the occupational medicine physician. 
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 SCREENING 
 
 
 
 
Screening is defined in one public health book as “[t]he use of technology and procedures 
to differentiate those individuals with signs or symptoms of disease from those less likely 
to have the disease” (Turnock, 2001).  The use of the dermatologic exam as a screening 
process to determine skin cancer is the basis for all statements forward.  Therefore, the 
definition and application of principles of cancer screening must first be applied to 
dermatology.   
The primary goal of screening is to reduce morbidity and mortality by detecting 
disease and treating earlier than in the absence of screening (Cole and Morrison, 1980; 
Miller, 1985; Parkin and Day, 1985; Spratt, 1982).  Furthermore, the use of screening is 
optimal when the following four conditions are met: first, the disease causes significant 
morbidity and mortality and the disease is highly prevalent; second, the disease’s natural 
history is known; third, a treatment exists and its early implementation can reduce 
morbidity or mortality; finally, a safe, inexpensive screening test exists (Koh et al., 1989).  
A review of the literature suggests that screening for skin cancer has great potential with 
regards to these conditions.  The application of skin cancer screening to the occupational 
setting will also be outlined.   
Melanoma and NMSC are, indeed, highly prevalent and cause significant 
morbidity and mortality.  Skin cancer affects more than 1,000,000 Americans per year 
and is the most common cancer in the United States.  Skin cancer accounts for 
approximately 2% of all cancer deaths (American Cancer Society, 2004), while non-
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melanoma skin cancer accounts for half of all human malignancies annually (Jemal et al., 
2002).  Of the over 10,000 deaths from skin cancer per year, melanoma accounts for 
roughly three fourths (American Cancer Society, 2004).  Mortality from melanoma has 
increased since the 1970s, particularly in white males (Wingo et al., 1998; Hall et al., 
1999).  The incidence of melanoma has increased an average of 6% per year between 
1973 and 1995; incidence rates continue to rise yearly, though at a lesser rate (Ries et al., 
2004).  In 2004, approximately 55,100 Americans are expected to develop melanoma, of 
which 7,910 are expected to die (American Cancer Society, 2004).  
The natural histories of both melanoma and NMSC have been determined.  
Extensive research on melanoma and prognostic outcome provides staging and long-term 
survival rate.  Depth of lesion upon discovery is the greatest determinant of clinical 
outcome, although other factors, including ulceration, elevated serum lactate 
dehydrogenase, lymph node and lung metastases have been incorporated recently.  The 
American Joint Committee on Cancer (AJCC) staging for cutaneous melanoma altered 
staging guidelines for clinical outcome in 2002.  
Traditionally, melanomas were microscopically staged by Breslow depth and 
Clark classification.  Breslow depth is the depth or thickness of the lesion in millimeters 
from top to bottom, while the Clark classification is based upon which layers of skin have 
been invaded by the melanoma, and are graded I- V (Table 1). 
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Table 1: Clark Classification System 
Clark’s Definition of 
Tumor Invasion
Clark 
Classification
Tumor confined to 
epidermis (not considered 
invasive) 
I 
Melanoma cells in 
papillary dermis 
II 
Melanoma cells filling 
papillary dermis 
III 
Melanoma cells in reticular 
dermis 
IV 
Melanoma cells in 
subcutaneous fat 
V 
 
However, with the new AJCC guidelines, melanoma is classified into the TNM 
system by many factors to predict severity of clinical course. A summary of the new 
correlation of Breslow depth to the T classification of the TNM system is found in Table 
2. 
 
Table 2: T Staging and Breslow Depth of Melanomas 
T 
Classification
Breslow Depth of Invasion
T1 > 1.0 mm 
T2 1.01- 2.0 mm 
T3 2.01- 4.0 mm 
T4 > 4.0 mm 
 
The dermal level of invasion, the Clark classification, is now only used in 
classification of thin melanomas, that is, melanomas in the T1 category.  This new system 
of classification incorporates Clark classification system and ulceration status to 
determine whether a T1 melanoma is of risk category “a” or “b.”  Category T1a includes 
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non-ulcerated melanomas of less than or equal to 1 millimeter in thickness (Breslow 
depth) and Clark level II or III.  Category T1b includes melanomas of thickness 1 
millimeter or less that have ulcerated or are Clark level IV or V.  In T2 stage melanomas 
or above, the “a” classification denotes no ulceration while the “b” classification denotes 
ulceration. 
Superficial, early-stage lesions have excellent long-term outcomes, whereas 
deeper, late-stage lesions predict higher mortality.  Melanoma tumor thickness is 
associated with 5-year survival rates.  Tumors less than 1.0 mm thickness have excellent 
5-year survival rates, whereas those thicker than 4.0 mm at diagnosis predict a poor 
survival rate at 5 years.  Detailed rates can be found in Table 3, based only on thickness 
and assuming no nodal or lung metastases, N0M0 (Balch et al., 2001).   
 
Table 3: Melanoma Five-Year Survival Rates 
Tx N0M0 
Classification 
Mean Survival (%) 
5 Year                       10 Year 
T1a 95.3 87.9 
T1b 90.9 83.1 
T2a 89.0 79.2 
T2b 77.4 64.4 
T3a 78.7 63.8 
T3b 63.0 50.8 
T4a 67.4 53.9 
T4b 45.1 32.3 
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Non-melanoma skin cancer is associated with slower, local invasion.  Squamous 
cell skin cancer is more likely to metastasize than most basal cell cancers.  However, 
poorer prognoses are associated with certain NMSC locations including the scalp, 
nasolabial folds, and post-auricular areas (Marks, 1981).  
Early treatment of skin cancer can, indeed, reduce morbidity and mortality.  An 
ideal screening situation would involve disease with a long detectable preclinical phase in 
which detection would result in earlier, advantageous treatment.  Certainly melanoma 
qualifies as a disease with preclinical, detectable phase, known as its radial-growth phase.  
In many situations, this preclinical phase can last months to years (Mihm and Fitzpatrick, 
1976).  Dysplastic nevi and other precursors to melanoma may further extend this 
preclinical phase for detection (Koh et al. JAAD, 1989).  Nonmelanoma skin cancer 
grows slowly, also providing a preclinical phase.  Actinic keratoses, easily identified and 
treatable potential precursors to squamous cell carcinomas, are theoretical targets for 
detection in preclinical screening. 
The visual skin examination is the primary mode of screening for skin cancer.  It 
is noninvasive, inexpensive, and requires no advanced technology.  Visual skin 
examinations are safe and painless, and one study reports high patient acceptance of such 
screening for cancer detection (Boyce and Bernhard, 1986).  However, the validity of 
visual skin cancer screening in detecting cancer has not been tested by randomized trials 
(Koh et al., JAAD, 1993).   
Many obstacles face the completion of a randomized trial.  Because of the long 
latency period of skin cancer, a prospective randomized trial, which would require large 
numbers of participants, would be both daunting and costly.  Although some completed 
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studies report the endpoint as skin cancers found during screening, there exists a self-
selection bias of the population screened.  Many published studies are hospital-based, and 
certainly there is a highly-selected population being screened.  On the contrary, 
community-based screenings have been completed, but follow-up of these patients is 
extremely difficult, especially with the patient privacy legislation in the United States.  
Pathology testing is also required for diagnosis confirmation, and this is rarely included 
in published studies due to cost as well as destruction/treatment of NMSC lesions.  There 
is also underreporting of melanoma cases in national data. 
The accuracy of visual screening examination in detecting cancer depends upon 
the test’s sensitivity, specificity, and predictive value.  A summary of these parameters 
(outlined by Koh et al., J Am Acad Dermatol 1989) from published screening 
examinations for melanoma is in Table 4.  
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Table 4: Parameters of Visual Screening Examination for Melanoma 
Study Examiner Sensitivity Specificity Positive Predictive 
Value 
Swerdlow, 
1952 
Physician 73% 
(16/22) 
98% 
(545/556) 
59% 
(16/27) 
Becker, 1954 Physician - - 43% 
McMullan & 
Hubener, 1956 
Dermatologists - - 38% 
(44/115) 
Lightstone et 
al., 1965 
Skin Cancer 
Specialists 
89% 
(893/1004) 
92% 
(1840/2006) 
84% 
(893/1059) 
Kopf et al., 
1975 
Skin Cancer 
Specialists 
77% 
(76/99) 
99% 
(5420/5439) 
80% 
(76/95) 
Grin et al., 
1990 
Dermatologists 81% 
(214/265) 
99% 
(10,357/10436) 
73% 
(214/293) 
Koh et al., 1990 Dermatologists 97% - 35-40%* 
Rampen et al., 
1995 
Dermatologists 93% 98% 54% 
*Low number: True Positives/Total screened, high number: True Positives /Total 
followed 
 
 
Table 4 illustrates various studies and screening parameters for visual 
dermatologic screening exam for melanoma.  While visual screening exam does vary in 
this group of studies for sensitivity (73-97%), specificity (92-99%) and positive 
predictive value (35-84%), it should be compared with other screening modalities.  Breast 
cancer screening using mammograms has a 77% to 95% sensitivity and specificity of 
94% to 97% (USPSTF, Aug 2002).   Colon cancer screening with fecal occult blood 
testing has a sensitivity of 40% and specificity of 96% to 98% for colon cancer (USPSTF, 
July 2002).  Finally, the pap smear dry slide detection for cervical cancer has a sensitivity 
of 60% to 80% for high-grade lesions, and lower for low-grade lesions (USPSTF, 2003).  
A summary of preventative health screening parameters is found in Table 5.  
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Table 5: Preventative Health Screening Tests Compared to Visual Skin 
Examination 
 
Test Prevention 
Target 
Sensitivity Specificity 
Mammogram Breast Cancer 77% -95% 94% to 97% 
Fecal Occult 
Blood 
Colon Cancer 40% 96% to 98% 
Pap Smear (Dry 
Slide 
Preparation) 
Cervical Cancer 60% to 80% for 
high-grade 
lesions 
- 
Visual Skin 
Exam* 
Melanoma  73-97% 92-99% 
* Data from Table 4 
 
Therefore, compared with other accepted cancer screening modalities, the visual 
skin exam is a reasonable screening tool in detecting melanoma, with parameters similar 
to other accepted modes of cancer screening. 
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SKIN CANCER SCREENING EFFORTS IN THE UNITED STATES 
 
 
 
 
Skin cancer screening in the United States has been greatly supported by the American 
Academy of Dermatology.  The group has spearheaded a campaign throughout the 
United States combining melanoma and skin cancer education with free community skin 
cancer examinations.  This effort has been in effect since 1985, and analysis of the data 
collected for 15 years (through 1999) was analyzed and published.  Since this is by far 
the largest screening effort in the United States for skin cancer, discussion of the results 
of this ongoing effort will be presented, and other smaller-scale screening efforts in the 
United States will follow. 
 The American Academy of Dermatology used a systematic approach to both 
recruit screenees and gather data to be analyzed.  The AAD promoted its free screenings 
though community media, including public service announcements on the radio, 
television, newspapers and posters.  The first step in the process was the completion of a 
standard form by the patient.  This form included information on demographics including 
age, sex, race, and educational level.  Healthcare access and services were also described, 
including details about medical insurance, whether the patient had a current or past 
dermatologist, whether the patient received a previous skin cancer screening from AAD 
or other physician, and the likelihood of the patient having a skin cancer screening 
without the AAD service.  Risk factors for melanoma were also asked, including personal 
and family history of melanoma or skin cancer, moles changing in size, color, shape, and 
skin type categorized I-IV.  Finally, how the patient heard about the screening was 
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recorded.  A consent form was signed to perform the screening as well as release of 
medical information should a suspicious lesion be identified in the screening.   
 Next, the patient received a skin cancer screening by a volunteer dermatologist.  
Findings were recorded by presumptive diagnosis in check-box form.  The diagnoses 
available were: actinic keratosis, dysplastic nevus, congenital nevus, basal cell 
carcinoma, squamous cell carcinoma, melanoma, and “other.”  Also recorded was 
whether a referral for follow-up was made.  If no lesions were found, the patient was 
informed that no further diagnosis or treatment was needed.  However, in the case of a 
suspect lesion (or lesions), the screenee was told to contact his or her primary care 
physician or dermatologist for further work-up.  If the patient was without a physician of 
any type, a referral was made.  No biopsies were performed on site.   
 From 1992-1994, the study tracked potential melanoma patients (those with 
suspected melanoma or lentigo maligna at screening) to determine final diagnostic 
outcome.  These patients were followed by telephone or mail, and the final biopsy report 
was requested if performed.  During this three-year period, 282,555 people were screened 
and 4,458 patients had one or more suspected melanomas (1.58%).  Ninety-six percent 
(96%) of the 4458 in question were contacted, and the study obtained confirmed 
pathology reports on 72.6% (3237 of 4458).  Of the remaining participants who did not 
obtain final pathology reports, most did not make follow-up appointments with a 
physician after screening.   
 In the same two year period (from 1992 to 1994), 371 melanomas were confirmed 
in 364 screenees.  There were more men (59%, 214) than women (41%, 150) in this 
group with a mean age of 58 years.  Sites of melanomas included upper extremities 
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(30%), lower extremities (18%), back (23%), head and neck (20%), chest and abdomen 
(9%).  Of the 97% known histopathologic diagnosis of melanomas found, 47% were 
superficial spreading, 42% were melanoma in situ, and 4% were nodular melanoma.  
Table 6 outlines the stage and thickness of melanomas found during this 2-year period.   
 
Table 6: Depth and Thickness of Melanomas Found in AAD Screening  
1992-1994 
 
Stage or Thickness (mm) Number Percentage (%) 
In Situ 151 41.9 
Invasive 
   <0.76 
   0.76-1.50 
   1.51-3.99 
   ≥4.00 
   Unknown 
209 
126 
54 
22 
4 
3 
58.0 
61.2 
26.2 
10.7 
1.9 
Local and Early Stage (In Situ + Invasive) 360 98.9 
Late Stage (Distant and Regional)  4 1.1 
All Cases 364 100 
Data from: Koh HK et al.,  J Am Acad Dermatol 1996. 
 
 When comparing this study to the SEER database, there was a statistically 
significant difference between the percentages of advanced melanomas.  That is, the 
proportion of melanomas with depth of 1.5 mm and greater was statistically smaller in 
the AAD screening study when compared to SEER registries in 1990.  SEER registry of 
1990 had 16.9% advanced melanomas (of all melanomas with known stage) and the 
AAD study from 1992-1994 had 8.3% advanced melanomas with a p=0.01  (Koh et al. 
JAAD, 1996).  This may suggest that a grassroots community screening such as that 
performed by the American Academy of Dermatology could detect melanomas at an 
earlier stage.  
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 Furthermore, many of the participants with melanoma may not have visited a 
physician for a skin examination in the absence of the free AAD screening.  In the health 
care access questionnaire completed before the screening, 39% of screenees with 
histopathologically determined melanoma reported that they would not have seen a 
physician otherwise.  Adding to this, 17% of screenees with confirmed melanomas stated 
that they had no health insurance (Koh et al. JAAD, 1996).  These data suggest that the 
free skin cancer screening may fulfill a need in the public health of the community, 
though the AAD participants may not represent the general population cohort secondary 
to self-selection. 
 In this study, the yield of screen-confirmed melanomas was 129/100,000 people 
screened.  However, screening of people 50 years of age or older had a higher yield of 
melanoma than of people below 50 years of age (161/100,000 vs. 89 of 100,000).  It is 
important to note that men had double the yield of melanoma than women (190/100,000 
vs 89/100,000).  The highest yield population was men older than 50 years of age, with 
240 screen-confirmed melanomas per 100,000 people screened (Koh et al. JAAD, 1996).  
This could certainly aid in the targeting of a high-yield population (men age greater than 
50) in developing a skin cancer screening program.   
 The positive predictive value of skin cancer screening evaluation in this study was 
calculated separately for different presumptive diagnoses.  For a presumptive diagnosis of 
melanoma, the positive predictive value was 17%.  This varied from 22.0% in 1992 to a 
low of 9.1% in 1993.  However, with a presumptive screening diagnosis of “rule-out 
melanoma” or “rule-out lentigo maligna,” the positive predictive value fell to 6.3% 
overall.  This lower positive predictive value, as compared to the 35-40% in the 
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Massachusetts study (Koh et al., 1990), could not be explained by the authors (Koh et al. 
JAAD, 1996). 
 Several reflections can be made from this large-scale study, the only one of its 
kind in the United States to date.  While the yield of melanoma diagnoses was 129 per 
100,000 people screened, it is presumed that this number would increase had all 
participants had follow-up biopsy.  The highest yield population for melanoma in this 
study was men over the age of 50; they comprised 24% of screenees.  It is possible that 
the “rule-out melanoma” diagnosis was a deterrent to follow-up as compared to the 
presumptive diagnosis of melanoma.  In fact, the vast majority of the 20% of screenees 
who did not have follow-up fell into the “rule-out melanoma” category.  Perhaps there 
was some ambivalence transmitted from physician to screenee, and this may account for 
poorer follow-up within this diagnosis.   
 A subset of this large database of the American Academy of Dermatology 
screening effort was analyzed and published in 1989.  This analysis consisted of 
screenees in Massachusetts during the years 1986 and 1987.  Fourteen centers in the state 
pooled their data for this publication and analysis.  In total, 2560 people were screened 
for melanoma/ skin cancer in 1986 and 1987.  Of these, 459 screenees had suspected 
melanoma/skin cancer, dysplastic nevi, and congenital nevi.  Sixty-three percent of these 
screenees had follow-up, 22% chose to have no follow-up, and the remaining were 
unable to be contacted.  Of those followed, the yield of diagnoses is found in Table 7.   
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Table 7: Yield of AAD Screening 1986-1987 in Massachusetts  
Presumptive Diagnosis Total Number 
Screenees with 
Diagnosis 
 Biopsy-Proven 
Diagnosis 
% Biopsy- 
Proven 
Diagnosis 
Melanoma 9 9 100 
Squamous Cell Carcinoma 9 7 78 
Basal Cell Carcinoma 82 54 66 
Dysplastic Nevus  39 27 69 
Congenital Nevus 3 3 100 
Total 142 100 70 
Data from: Koh HK et al., Cancer 1990. 
 
Therefore, of the 142 diagnosed lesions, 70%, or 100 lesions were pathologically 
confirmed by biopsy.  The authors calculated the prevalence of skin cancer in the general 
population and determined that the screening attracted 7 to 70 times more people with 
skin cancer (a self-selection, most likely).  Their yield range of one melanoma per 280 to 
510 screenees (Koh et al. Cancer, 1989) is approximately on target with other large 
studies (Miller, 1985; Morrison, 1985).  The authors did suggest following some of the 
negative screenees in future studies to be able to calculate the specificity of the visual 
examination to determine a false-negative rate (Koh et al. Cancer, 1989).  It is likely that 
this subset is similar to other subsets throughout the country. 
From the same skin cancer screening program performed by the American 
Academy of Dermatology, an analysis of the first 15 years (1985-1999) was published in 
2003.  Methods were as described before, however forms were counted in the AAD 
central office and recorded in annual summaries.  These yearly summaries were amassed 
into a master file at Boston University.  Years 1985, 1995 and 1996 (a total of 205,000 
forms) were unavailable and could not be studied.  The authors performed a number of 
analyses on the information to provide insight into the study and clinical outcome.   
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Demographics of this screening effort were summarized.  From 1985-1999, 
1,024,350 screenings were performed on approximately 800,000 individuals (accounting 
for repeat screenees).  All states including the District of Columbia were included by 
1994.  The states with the greatest number of screenings per whites in the state were Iowa 
(1 in 89), New Jersey (1 in 93) and Kentucky (1 in 95).  Screenees were 95% white non-
Hispanic and 61% were women.  Median age of participants was 52 years, with a range 
of 1 to 101.  The largest age group of participants was age 51-65 years (29%) and age 36 
to 50 (25%).  The highest educational level for 41% of participants was high school, 
followed by college (37%) and then graduate school (18%).   
Major risk factors for skin cancer were obtained on the questionnaire.  Almost 
two-thirds of screenees had 1 risk factor for skin cancer, and one third had at least 2 risk 
factors.  These included a changing mole (33%), skin type I or II (37%), personal history 
of melanoma (3%), family history of melanoma (8%), personal history of nonmelanoma 
skin cancer (11%) or family history of nonmelanoma skin cancer (20%).  Interestingly, 
forty-seven percent of those with confirmed melanoma had 2 or more risk factors, forty-
one percent of those with basal cell carcinoma, and forty-percent of those with squamous 
cell carcinoma.  However, only 27% of those with normal screening had 2 or more risk 
factors.   
As expected, the repeat screenees had a higher percentage of risk factors (39-40% 
on average) as compared to first-time screenees (29-30%, on average).  They also had a 
higher likelihood than first-time screenees of having presumptive diagnosis of squamous 
cell carcinoma (1.5% vs. 1.1%, p<0.05), basal cell carcinoma (7.6% vs. 6.1%, p<0.01), 
and actinic keratosis (21% vs. 16%, p<0.001).  This suggests the benefit of annual 
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screening of high-risk patients (Geller et al., 2003).  There was no significant difference 
between first-time and repeat screenees in percentage of presumptive diagnosis of 
melanoma, although there could be multiple factors accounting for this, including higher 
likelihood of finding melanoma on first screening.   
During these first 15 years, the screenees’ access to care was analyzed.  Although 
only 8% did not have health insurance, almost 80% did not have a dermatologist and 78% 
reported never having an AAD skin cancer screening and were “first-time” screenees.  
Sixty percent stated that they had never had their skin checked for skin cancer, and 51% 
reported that they would not have seen a doctor for a skin cancer screening had it not 
been for the free AAD skin cancer screening.  Of interest, those with a confirmed 
diagnosis of melanoma through the AAD free skin cancer program had higher rates of not 
having a dermatologist (86%), being uninsured (16%), and for being first-time screenees 
(88%).  It was estimated that 1 in 100 screenees had a presumptive diagnosis of possible 
melanoma. 
The persons screened by the AAD in the free skin cancer project report some 
significant differences with that of the general population.  They reported higher rates 
(14%) of personal history of melanoma and nonmelanoma skin cancer (Geller et al., 
2003), as compared to less than 1% obtained in a household survey of 30,000 US citizens 
in 1992 (Hall et al., 1997).  As compared to US population controls, screenees were 
almost twice as likely (40% vs. 22%) to report ever having a skin cancer screening 
(National Center for Health Statistics, 1997).  While there appears to be some self-
selection of people attending the AAD free skin cancer screenings, the repeated high rates 
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of multiple skin cancer risk factors among new screenees suggests that the screening 
continued to recruit new at-risk participants yearly.   
Another study was performed by dermatologists in Northern California authored 
by Swetter et al.  Veterans in the San Francisco bay area who were not registered as VA 
patients for the previous three years were targeted to receive free skin cancer screenings.  
Methods of screening were similar to that of the AAD skin cancer screening; participants 
completed a questionnaire, and following screening participants were encouraged to 
follow-up with a dermatologist depending on the presumptive diagnoses.   
Between March 1997 and May 2000, twenty screenings occurred in the northern 
California area.  Of the 374 people screened, 362 were male and mean age was 63.4 
years.  The majority of screenees were Caucasian (74%) and highest educational level 
was college (42%) followed by high school (35%).  The majority of participants (79%) 
did not have a dermatologist, 50% reported never having a skin cancer check by a doctor, 
and 71% stated they had not had a prior skin cancer screening.   
While Caucasians accounted for the majority of screenees (74%), they 
represented 65% of participants with presumptive skin cancer and non-cancer diagnoses.  
Age groups were stratified for presumptive diagnoses.  Two participants were 90+ years 
of age, and both had suspicious lesions.  In the 70-79 year old age group, 81% of 
participants had suspicious lesion, followed by 80-89 (63%), 60-69 (55%), 40-49 (34%) 
and 50-59 (30%).   
Fifty-percent of participants with suspicious skin lesions followed-up at a 
Veteran’s Affairs Palo Alto Health Care System.  Biopsies were performed as 
appropriate.  Positive predictive values were reported as a range, with the lower end 
 19
accounting for the participants with suspicious lesions who did not follow-up, and the 
higher end point excluding them.  The range of positive predictive value of visual skin 
cancer screening was 31-62% for basal cell carcinoma, 33-43% for squamous cell 
carcinoma, 21-37.5% for dysplastic nevus, and 7-12.5% for melanoma.   
This study had an older mean age of participants than the AAD screening, and 
had the men as the majority of participants.  The risk factor profile of screenees was 
otherwise similar to that of the AAD screening.  They had a higher referral rate for 
follow-up (50%) than the AAD screening, but this may be due to the higher prevalence of 
NMSC in the population screened.  Other studies such as the AAD screening points to 
older Caucasian men as being a high-risk group for nonmelanoma and melanoma skin 
cancer; this study had a predominance of this high-risk group.  
Swetter et al. devised the study such that follow-up with a dermatologist would be 
easy and convenient for the screenees with a suspicious lesion; it was still troublesome 
that only 50% chose to follow-up.  While 17% of the remaining state that they would 
follow-up elsewhere, the remaining 37% were assumed to have no follow-up at all, 
despite the ease of follow-up and VA benefits (Swetter et al., 2003).  This suggests that 
even when targeting a higher-risk population, screenee follow-up may be a challenge. 
These studies shed light on the state of skin cancer screening in the United States.  
The American Academy of Dermatology has performed widespread screening.  Multiple 
lessons have been learned, while additional questions have been raised regarding the best 
practices on such a large-scale effort.  Smaller-scale studies, particularly the VA study 
targeting higher-risk populations, offer insight into detection, as well as complexities in 
follow-up care.  While these are some of the most prominent studies of skin cancer 
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screening in the United States, it is important to investigate similar efforts performed 
internationally.   
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INTERNATIONAL SKIN CANCER SCREENING EFFORTS 
 
 
 
 
A comprehensive literature review was performed on international skin cancer screening 
efforts.  Some collaborative efforts exist both among and within certain nations.  For the 
most part, developed countries have published articles regarding skin cancer screening 
while developing countries are poorly represented.  It is surmised that developing 
countries have fewer public health resources, and available resources are allocated to 
more acute, life-threatening diseases.  Infectious disease such as tuberculosis, malaria, 
and food-borne illness would obviously be a greater priority in these nations than skin 
cancer screening.  Research performed internationally regarding skin cancer screening 
will be presented, with particular emphasis placed on any application or comparison of 
results with respect to the United States.   
 The global burden of cancer continues to grow.  In the year 2000, it is estimated 
that 10 million new cases of cancer were diagnosed worldwide (excluding nonmelanoma 
skin cancer).  Melanoma skin cancer continues to increase worldwide.  Internationally, 
the incidence rate of melanoma varies 100-fold.  The highest rates of melanoma are 
found in Queensland, Australia, where people of northern European descent settled.  This 
area is close to the Equator, and the rate of melanoma is approaching 40 cases per 
100,000 people per year.   
However, incidence of melanoma is rising internationally (Boyle, 1997).  Of note, 
migrants from a low-incidence area (such as Europe) who settle in a high-incidence area 
(such as Queensland) acquire a higher incidence rate than native-born people in the high-
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incidence area (McCredie et al., 1990).  Furthermore, even in countries with low rates of 
melanoma (such as Japan) there has been a drastic increase in melanoma incidence in 
both sexes (Muir and Nectoux, 1982).  Average annual melanoma incidence rate 
increases are highest in the Nordic countries (6%), New Zealand (7%), and in the Jewish 
population of Israel (11%).  Despite changes in diagnostic criteria of melanoma, it is 
widely accepted that the increase in melanoma in the last 60 years is a real trend (Van der 
Esch et al., 1991).   
 
 
 
 
EUROPEAN COLLABORATION 
 
 
Multiple studies have been published in Europe, some stemming from collaborative 
efforts and others from individual countries.  Multiple papers concur that mortality from 
melanoma has been increasing in Europe until recently (Francesci et al., 1992; Thorn et 
al., 1992; Balzi et al., 1997).  In the late 1990s, skin cancer mortality rates were highest in 
Scandinavian countries (2.5 to 3.7/100,000 in men and 1.6 to 2.2/100,000 in women), 
while southern Europe had the lowest mortality rates from skin cancer (1.3 to 2.1/100,000 
for men and 0.8 to 1.4/100,000 for women).  This statistical difference between countries 
is narrowing (Levi et al., 1998; Levi et al., 2004). 
It appears that this mortality trend is leveling off in Europe as it is in the United 
States (Scotto et al., 1991; Severi et al., 2000).  This slowing may be due to many factors, 
including increased awareness (La Vecchia and Bosetti, 2004).  Early prevention 
campaigns and intervention programs likely have contributed to this trend as well 
(Williams et al., 1990; Hill et al., 1993; Koh and Geller, 1995; MacKie et al., 1997; Melia 
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et al., 2000).  Studies in some countries have found decreases in melanoma thickness, one 
of the prognostic factors of melanoma, perhaps suggesting earlier detection (Thorn et al., 
1994; MacKie, 1998; Carli et al, 2003).  La Vecchia and Bosetti strongly urge the 
implementation and support of prevention, detection and surveillance programs 
throughout Europe to decrease mortality from melanoma (2004).   
The European Society of Skin Cancer Prevention (EUROSKIN) was formed in 
June of 1999.  It was the first collaborative effort to address increasing skin cancer 
incidence in Europe.  The first conference occurred in May 2000, with collaboration with 
the World Health Organization (WHO), European Commission (EC), and the 
International Commission on Non-Ionizing Radiation Protection (ICNIRP).  
Recommendations regarding primary and secondary preventive measures were 
determined and published (Greinert et al., 2001).   
It was felt that the epidemiology of skin cancer needed improvement.  
EUROSKIN called for standardization and collaboration of information and data 
collection.  This would improve estimates of the true incidence rates of nonmelanoma 
skin cancers as well as true incidence rates of malignant melanoma.  One emphasis in 
achieving these goals was the screening for skin cancer as a “tool for control of the 
disease.”  A call was made for the complete registration and evaluation of the morbidity 
and mortality of skin cancer, as well as the incidence of skin cancer.  Investigation into 
the pros and cons of screening was proposed, including the accuracy of skin cancer 
screening (Greinert et al., 2001). 
Therefore, through EUROSKIN, the importance of skin cancer screening is being 
investigated with regard to multiple concerns.  The call for continent-wide research and 
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sharing of information again confirms the importance of skin cancer awareness in public 
health worldwide.  It is anticipated that future studies from this collaborative effort will 
be published and will perhaps provide further insight into the European view of skin 
cancer screening as definitive secondary skin cancer prevention.   
 
THE UNITED KINGDOM 
 
 
The incidence of melanoma in the United Kingdom is low, with annual incidence 10 per 
100,000.  Malignant melanoma accounted for 1265 deaths in the United Kingdom in 
1992, and nonmelanoma skin cancer caused 400 deaths per year (Holme et al. Clin Exp 
Dermatol, 2001; Osborne, 2002).  In 1999, the government instated new guidelines 
regarding the treatment of suspected skin cancer.  With the exception of basal cell 
carcinoma, patients with suspected skin cancer in the U.K. should be seen by a specialist 
within 2 weeks of referral from a general practitioner (Department of Health, 1999).   
 There are no formal skin cancer screening programs in the United Kingdom 
(Osborne, 2002).  However, a melanoma screening day was implemented in 1998.  The 
Swansea area was targeted in this study, as this area has the highest reported incidence 
rate of melanoma in the United Kingdom.  These incidence rates of melanoma are 
comparable to other western European countries and seemed optimal for screening.   
The screening day was modeled after the American Academy of Dermatology 
screening, with pamphlets and announcements throughout the community to advertise the 
event.  Upon arrival, the screenees completed a questionnaire much like that of the AAD, 
and the participant then received a skin examination by a dermatologist.  Lesions were 
recorded, including site, number, diagnosis and follow-up recommendations.  If a lesion 
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was suspicious, the participant’s general practitioner was contacted by telephone for 
permission to schedule excision.  If no contact was possible with the general practitioner, 
the screenee was scheduled for removal or biopsy and the general practitioner was 
contacted by mail.  Education regarding primary and secondary skin cancer prevention 
was also offered at the screening.   
Additionally, one year after the screening the 832 participants were contacted by 
mail using information on the initial questionnaire.  They were asked to complete a 
follow-up satisfaction and general health questionnaire.  Nine aspects of the screening 
were to be rated on a satisfaction scale, and six general health questions were to be 
answered.  There was also the opportunity for additional comments.  If participants did 
not respond, they were not followed-up any further.   
In total, 832 people (315 males, 517 females) were screened by 7 dermatologists 
in 10 hours.  Mean age was 54 years, with 57% aged greater than 50 years, and 24% were 
between 61 and 70 years.  Distribution of skin types was: type I, 12%; II, 29%; III, 43%; 
IV, 15% (in 1% skin type was not documented).  Location of lesions varied, though they 
were most commonly on the trunk (back 34%, front 22%), followed by the head and neck 
(21%), and finally the arms (10%) and legs (10%).  In 832 participants, 882 lesions were 
diagnosed clinically, including 6 suspected melanomas and 9 basal cell carcinomas. 
Of the 832 screenees, 72 were referred for follow-up.  All screenees with an 
appointment for biopsy or excision attended.  Ultimately 40 lesions were removed from 
31 participants.  Of these, there were three superficial spreading malignant melanomas 
confirmed histologically in three screenees; all had a Breslow thickness of < 0.75 mm.  
Therefore, this screening effort found melanoma in 1 out of 277 participants.  Further, the 
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response to the year- later audit was quite positive, and the majority of respondents were 
very satisfied with the screening.  
Although the screening effort did identify melanoma in a rate similar to other 
screenings in the United States, the authors of this study felt that such screenings were 
not widely applicable to the United Kingdom.  Because citizens of the UK have access to 
comprehensive primary health coverage, it is estimated that about 80% of individuals 
consult their general practitioner each year.  This coupled with the low background 
incidence of malignant melanoma supports the authors’ suggestion that it may be more 
cost and time effective for general practitioners to perform initial screening in high-risk 
patients for melanoma, then refer to a dermatologist if indicated (Holme et al. Br J 
Dermatol, 2001). 
In Scotland, there was concern that patients were not seeking timely care for 
suspect lesions.  This stimulated a campaign initiated in 1985 consisting of leaflet and 
media distribution publicizing the need for early care for suspect lesions.  All general 
practitioners in western Scotland received booklets titled, “An Illustrated Guide to Early 
Malignant Melanoma.”  It was around this time that the Cancer Research Campaign 
funded the pigmented lesion clinics discussed below.  Through these efforts, patient 
demand for specialty referral increased.  Public education programs may decrease 
mortality rates from skin cancer in women, though no decrease has been seen in men.  
However, thinner lesions are being reported (Doherty and MacKie, 1988; Ellman, 1991).  
This may translate into an increase in 5-year survival (Herd et al., 1995).   
One unique characteristic of the health system in the United Kingdom is the 
existence of pigmented lesion clinics, or PLCs.  Many centers throughout the United 
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Kingdom have established these specialty referral centers.  The patient population at 
these centers should be considered high-risk, as these patients have been pre-screened at a 
general practitioner’s office and referred for specialty care for suspicious lesions.  This is 
one example of ideal selected population screening when determining detection rates.  
Indeed, melanoma incidence rates at these pigmented lesion clinics range from an 
impressive 1 in 20 patients to 1 in 60 patients (Holme et al. Br J Dermatol, 2001; Herd et 
al., 1995; Grover et al., 1996; Kirkpatrick et al., 1995).  Osborne recommends further 
studies evaluating the PLC in terms of decreased mortality and cost-effectiveness in the 
United Kingdom (2002). 
 
 
AUSTRIA 
 
 
In 1988, Austria performed a public health campaign called the Austrian Melanoma 
Public Education Campaign.  This was an educational campaign for both physicians and 
the public regarding pigmented lesions and suspicious characteristics.  These pamphlets 
were distributed to all Austrian surgeons, dermatologists and general practitioners.  A 
study reported a statistically significant reduction in mean Breslow depth of melanoma in 
the year following the campaign, but an increase in the years following (Pehamberger et 
al., 1993).  It is surmised that such educational tools only provided a short-term benefit. 
One published study in Austria performed screenings at innovative locations.  A 
group of dermatologists devised a skin cancer screening study at large recreation centers 
in Styria, Austria.  The thought that people would be sunbathing and in a state of undress 
allowing a thorough examination at such centers supports the authors’ choice of 
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screening venue.  Furthermore, this population may be of higher risk, since many 
sunbathe at recreation centers and pools.   
 In July 1998, the authors performed skin cancer screenings at three large 
recreation centers.  Prior to screening, a questionnaire determining risk factors was 
completed by screenees.  In total, 344 individuals participated (159 females, 185 males).  
The average age was 36.1 years, with a range of 7 months to 89 years.  Of the 344, 45 
screenees (13%) were found to have suspicious lesions and were referred for follow-up 
care to local dermatologists.  Interestingly, eighteen of these participants (40%) were not 
planning to visit a physician in the coming 6 months, and 28 (62%) had never had a skin 
cancer screening examination prior to the study.   
 In all, the screening at the recreation center was well-received by the screenees.  
About 72% preferred the screening to a physician visit.  Moreover, this study had more 
men than women participants, which is encouraging as older men are thought to be at 
higher risk for melanoma.  This study was not designed with any follow-up, so biopsy-
confirmed diagnoses are not reported.  However, this study does raise the issue of 
community outreach and targeting populations open to screening (Hofmann-Wellenhof et 
al., 2000). 
 
 
BELGIUM 
 
 
A group in Belgium was inspired by educational and screening campaigns in the United 
States and in Scotland, and organized “Melanoma Monday.”  Leaders of this campaign 
banded together in the Melanoma Monday Task Force, surveyed dermatologists’ interest, 
and received approval from an ethics committee and scientific boards.  The date for 
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screening and education was set for Monday, April 26, 1999.  Media campaigns were 
initiated one month prior to the screening day.   
 Screening took place in participating dermatologists’ offices, clearly marked by 
participation posters and stickers.  The free screenings were by appointment, 2 hours in 
the morning and 2 in the evening.  Participants completed a screening questionnaire about 
risk factors for skin cancer.  If suspect lesions were discovered, the screenee received a 
letter to take to his or her general practitioner for further referral or treatment.   
 Of the 521 Belgian dermatologists, 340 (65%) participated in Melanoma Monday.  
In total, 2767 people were screened, with mean age 35 years.  There were about twice as 
many women as men who participated in the screening.  Of the 644 suspect lesions 
found, 503 were though to be atypical nevi.  However, 35 lesions were suspected 
melanoma, and 59 lesions were suspected basal cell carcinomas, and no squamous cell 
carcinomas were suspected.  The rate of melanoma suspicion in this study was high at 
greater than 1 out of every 100 screenees, and suspected basal cell carcinoma in greater 
than 2 out of every 100 screenees.   
 Although no biopsies were performed on Melanoma Monday, the participating 
dermatologists were queried one month after the screening.  Since only 70% of 
dermatologists answered, data is incomplete.  However, they reported that 25 melanomas 
were found on Melanoma Monday and later histologically proven.  The remaining 10 
melanomas may have been over diagnosed or cared for by general practitioner, surgeon 
or non-participating dermatologist.  Interestingly, in the month that followed Melanoma 
Monday, an additional 141 melanomas were found during regular dermatologist clinic 
hours.  This amount, added to the 25 from Melanoma Monday, demonstrated that 166 
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melanomas were found in one month by dermatologists only; the annual incidence of 
melanoma in Belgium is only 850-1150.  It is likely that the public educational campaign 
improved awareness in the community and increased diagnosis of melanoma (Vandaele 
et al., 2000).   
 
SWITZERLAND 
 
 
There was launch of an evaluation of epidemiologic melanoma skin cancer data in 
Switzerland.  A public health education campaign began in 1988 with an additional 
program in 1989.  A review of national data revealed a doubling of new melanoma 
diagnoses in the 2 months following the first educational campaign.  Similar to 
educational campaigns in other countries, there was a subsequent decrease in new cases 
after the surge.  Patients under age 60 comprised many of the new skin cancer cases 
(Buillard et al., 1992). 
 
 
DENMARK 
 
 
Olsen and Jensen analyzed cancer data from 1970-1979.  They report that melanoma 
accounted for 2.1% of all incident cancers in Denmark, while nonmelanoma skin cancers 
accounted for 12% of all malignancies in Denmark (1987).  The authors also provide an 
excellent association of skin cancer with occupation, and this will be addressed in the 
next chapter.   
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THE NETHERLANDS 
 
 
A group of dermatologists in the Netherlands modeled skin cancer screening efforts after 
the ones completed by the American Academy of Dermatology.  Two campaigns 
occurred, one in 1989 in Oss, a community of 110,000 inhabitants, and larger campaign 
in Arnhem, a community of 650,000 inhabitants.  Both screening efforts were combined 
in a published paper.  Media announcements focused on melanoma and skin cancer risk 
factors.  Screening occurred in a hospital setting, and screenees with suspicious lesions 
were referred to a specialist, as well as contacted four months later for follow-up.   
 In total, 2564 people were screened, 603 in Oss and 1961 in Arnhem.  Of these, 
262 screenees had suspicious lesions (10.2%), with 103 suspicious for skin cancer (4%).  
At the four-month follow-up, 93 of the 103 with suspected cancer had followed up (90%) 
and 128 of the 159 (80%) with precancerous or precursor lesions had followed up.  Of the 
screenees with suspected skin cancer, 52 people had 54 histologically confirmed 
malignancies (two screenees each had two malignancies).  One participant with a 
suspected dysplastic nevus actually had confirmed melanoma.  In effect, 53 screenees had 
55 histologically confirmed malignancies.  Among these, there were 9 melanomas, 1 
lentigo maligna, 40 basal cell carcinomas, and 5 Bowen’s disease.  Of the suspected 
cancerous lesions, the positive predictive value ranged from 50-56%, depending on the 
inclusion of screenees who did not follow-up.  The total cost of this screening was $6000.   
 The authors were encouraged by their results.  They noted that distance to 
screening site was a factor in participation, as the majority of participants lived in nearby 
areas.  Whether screening is a cost-effective measure in reducing mortality from 
melanoma is unknown and of interest in future studies (Rampen et al., 1991).  It is 
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notable that referral may differ in the Netherlands, particularly due to the health care 
system.  Follow-up in this study was immense, with a nearly 85% compliance rate.   
An additional study was completed in 1989 by Krol et al.  The authors organized 
a free skin cancer screening effort in the western area of the Netherlands along the beach.  
They used a mobile trailer as their screening venue.  In total, they screened 3069 people; 
suspicious lesions were found in 65 participants.  Of these, 6 people were confirmed 
histopathologically to have melanoma.  All six screenees had melanomas of less than 1 
mm Breslow depth.  Furthermore, in the 2 months following the screening and 
educational campaign, there was a modest increase in the number of benign and 
malignant skin lesions diagnosed in screenees (Krol et al., 1991). 
Although the United States differs in healthcare system, it is valuable to note the 
high follow-up rate in the first study.  Further investigation into the reason for such high 
follow-up (low cost, ease of appointments, locations, characteristics of the population) 
could be helpful in increasing skin cancer screening follow-up elsewhere.  Finally, it 
would have been helpful to know more about the demographics and skin cancer risk 
factors of the population screened.  
 
 
ITALY 
 
 
Cristofolini et al. began a public health campaign in Trentino, Italy to target the early 
detection of melanoma.  The program was started in 1977 and repeated in 1981.  It 
consisted of the distribution of a pamphlet regarding melanoma and many discussions in 
conferences, television programs and meetings.  The local hospital in Trento offered free 
consultations in the dermatology department.  The aim of the study was to determine the 
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mortality rate before and after the campaign in the population of outreach versus similar 
population lacking the educational campaign.  While this is not a screening effort per se, 
it was a valuable study worthy of inclusion of worldwide discussion of skin cancer 
screening efforts, as the goal of any screening effort is the reduction of morbidity and 
mortality.   
 The authors used mortality rates for melanoma from the death certificates at the 
Central Institute of Statistics.  They analyzed rates before, during, and after the 
educational campaign.  Rates from Trentino were compared with those from three 
bordering regions where the educational campaign was not available.  Standard mortality 
ratio (observed deaths/expected deaths) and the cumulative mortality rate was used in 
comparison data.  In Trentino, the change in cumulative mortality rates for women 
actually was a decrease in rate (-15%) after the campaign as compared to an increase in 
the other three regions (+82%, +75%, +33%).  Furthermore, the male cumulative 
mortality rate from melanoma in Trentino had a smaller increase than in surrounding 
regions (+35% vs +104%, +105%, +70%). 
Although the authors did not postulate why this large increase occurred in the 
surrounding areas, they focused on the difference between regions.  Cristofolini et al. 
believe that these changes are unlikely to have been due to chance alone.  They also 
applied this information to estimate the approximate number of lives “saved” by the 
campaign.  It was assumed that if the campaign had not occurred in Trentino, then the 
mortality rate from melanoma would be similar to that of the surrounding areas for the 
same time period.  In applying these three rates to the population of Trentino, 
approximately 21 to 31 more people would have died of melanoma in the same time 
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period, with an average of 24 people (Cristofolini et al., 1993).  Again, educational 
material coupled with free skin cancer screening appeared to increase melanoma 
awareness and screening in the population.   
 
 
CANADA 
 
 
Canada has offered free skin cancer screening clinics in many cities since 1991.  
However, the incidence of skin cancer and follow-up from these clinics has not been 
published.  A group from the Canadian Cancer Society and the Canadian Dermatology 
Association developed a study to analyze demographics of screenees, the follow-up 
pathology of suspicious lesions, and the positive predictive value of screening.  Other 
endpoints of evaluation included barriers to follow-up.  This study encompassed free skin 
cancer screening clinics in Vancouver and Parksville, British Columbia during years 
1994 and 1995.   
 Screenees completed a questionnaire similar to the one devised by the American 
Academy of Dermatology prior to screening.  The participants chose whether they 
wanted a full body examination, an examination of sun-exposed areas, or examination of 
a specific area.  A dermatologist performed the examination, and if there was a suspicious 
lesion, the screenee was referred to their dermatologist or family physician.  In 1996, 
those referred for follow-up were contacted by mail to complete information regarding 
any follow-up for skin lesions. If no response was received, they were then contacted by 
telephone and a second questionnaire was sent if necessary.  A separate questionnaire 
was sent to the screenees’ dermatologist or family physician to verify the final diagnosis 
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of suspected lesions.  A pathology report was requested if the lesion was biopsied or 
excised.   
 At the skin cancer screening clinics, 520 people were screened, consisting of 58% 
women and 42% men.  Average age was 39 years old, 40 years for men and 37.5 years 
for women.  In total 105 participants were referred for 177 suspicious lesions.  Of those 
referred, 93 responded to the survey and 80 (80/93, 86%) sought medical follow-up.  The 
authors were able to obtain diagnoses on 76 participants; melanoma was suspected in 6 
people (1 was biopsy-confirmed), 10 had suspected basal cell carcinoma (3 were biopsy-
confirmed) and 2 people had suspected squamous cell carcinoma.  No squamous cell 
carcinomas were biopsied, but 2 out of 3 were clinically agreed upon.  The positive 
predictive value for lesions varied: 17% for melanoma, 43% for basal cell carcinoma, 
19% for atypical nevus and 89% for actinic keratosis.  
Of the 13 people who did not follow-up, several reasons were given.  Five 
screenees did not understand that they should follow-up, two forgot to follow-up, two 
claimed that they had no physician with whom to follow-up, one followed up with a 
nonphysician, one was still planning to follow-up. Two people gave no reason for not 
following up.  None of these participants had a lesion suspicious for melanoma.  
Interestingly, there was one false-negative case of biopsy-confirmed in situ melanoma on 
a screenee’s leg reported by a dermatologist on follow-up.  This study reinforces the need 
for focusing on older patients as a higher-risk population.  Only half of the screenees 
were older than 40 years of age, but they comprised 66% of participants referred for 
follow-up. Additionally, although only 10% of screenees were 65 years of age or older, 
one out of four in this age group were referred for follow-up (Engelberg et al., 1999).  
 36
BRAZIL 
 
 
A study was performed by Passos da Rocha et al. in Brazil to estimate the prevalence of 
pre-malignant and malignant skin lesions in a population in southern Brazil.  As a 
secondary measure, the authors aimed to determine the sensitivity and specificity of skin 
cancer screening.  Forty-eight randomly selected census tracts were selected from an 
urban area in southern Brazil on which to perform a cross-sectional population-based 
study outlined above. 
In total, 1,292 people were interviewed after the investigators visited 2,112 homes 
in the area.  All participants were 50 years of age or older.  A questionnaire was 
completed inquiring about any new skin lesions in the last 6 months or any lesions on 
sun-exposed areas.  Any participants with positive answers were referred to the 
university’s dermatology clinic for visual skin cancer screening.  However, in order to 
determine specificity, a control sample of those who answered negatively was also 
examined.   
In this study, the prevalence of pre-malignant and malignant skin lesions was 
20.7%.  The authors reported screening sensitivity was 20.1% and specificity was 86.9%.  
Positive predictive value was 29%, negative predictive value was 80.4% and accuracy of 
diagnosis 72.9%.  The authors concluded that in this population in Brazil, there was a 
high prevalence of skin cancer and pre-skin cancer lesions.  They found the parameters of 
the visual skin cancer screening exam to have low sensitivity and “unsatisfactory” 
specificity (Passos da Rocha et al., 2002).   
This study may not be generalizable, as the population chosen may not represent 
other populations, and the visual screening skills of the dermatologists may vary from 
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region or university to region or university.  However, such an effort in skin cancer 
screening is admirable, considering the number of homes visited and recruitment of many 
people over 50 years of age.  One could postulate that Brazil, by location, may have a 
high prevalence of skin cancer secondary to proximity to the equator, however, skin type 
III or IV may be protective against harmful UV radiation.   
 
 
JAPAN 
 
 
Nagano et al. devised a screening study in Japan to determine the incidence and 
prevalence of nonmelanoma skin cancer in the southernmost tip of Japan, where annual 
UV radiation cumulative dose is the highest  (1999).  Previous studies performed in Japan 
demonstrated a five-fold higher number of patients with nonmelanoma skin cancer and 
actinic keratosis in the southernmost part of Japan as compared to the north (Suzuki et al., 
1996).  Another study performed at the near geographical center of Japan in Kasai City 
aimed to determine the incidence and prevalence of skin cancer in this population.  A 
total of 4736 people were screened in 1993 and 36 actinic keratoses were found.  
Additionally, two cases of basal cell carcinoma were also diagnosed in this screening.  
The study determined a prevalence rate of 414 actinic keratoses per 100,000 Japanese 
people in this region (Naruse et al., 1997; Suzuki et al., 1997).   
 Nagano et al. targeted the Ie Island in the Okinawa Prefecture, as it is at the 
southernmost part of Japan.  The island has a population of 5562 and its mainstay of 
economy is the cultivation of sugar cane and fishery.  The skin cancer screening was part 
of a public health effort to screen for various cancers among persons over age 40.  Using 
the Health Science’s Law for the Aged, this population over age 40 was encouraged to 
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participate.  In total, 1690 people (65% of residents in this age group registered as 
residents under the Health Law) participated (717 men and 973 women).  The study took 
place over 1993 to 1996 and many participants were screened in consecutive years.   
 Skin cancer screenees completed a questionnaire regarding demographics as well 
as skin cancer risk factors.  Dermatologists performed visual skin cancer screenings and 
biopsies were performed on any suspicious lesions.  Among the screenees, 86 cases of 
actinic keratosis, 9 cases of basal cell cancer, and 2 cases of squamous cell cancer were 
histopathologically confirmed.  No malignant melanoma was found during the study.  
Annual prevalence of actinic keratosis as compared to that of centrally located Kasai City 
is found in Table 8. 
 
Table 8 Annual Prevalence of Actinic Keratosis in Ie Island and Kasai City  
Location Year Number of 
Screenees 
Number 
of Cases 
Prevalence* OR 95% CI 
Kasai City+ 1992 4736 36 414.3 1.00 --- 
       
Ie Island# 1993 1118 37 1159.4 2.79 2.03-3.78 
 1994 1117 18 572.8 1.38 1.15-1.64 
 1995 1014 24 1014.3 2.45 1.85-3.18 
 1996 1035 31 988.9 2.39 1.84-3.09 
*After standardization to the 1990 Japanese population 
+Data from: Slaper et al.,1996. 
#Data from: Nagano et al., 1999.   
 
 This study demonstrates the increased prevalence of actinic keratosis with 
increased UV radiation in Japan (Nagano et al., 1999).  It was interesting that no 
melanomas were diagnosed in this study.  There may be a protective effect in either 
environmental or genetic factors among the Japanese, but analyzing death certificates for 
malignant melanoma may be of interest.  Additionally, many actinic keratoses were 
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diagnosed, but only two squamous cell carcinomas were found.  Because very few actinic 
keratoses evolve into squamous cell carcinoma, the screening for actinic keratoses may 
not be cost-effective in reducing mortality in this population.  However, the study’s 
strong association between UV radiation and actinic keratosis prevalence is quite evident 
and may be helpful in targeting populations at higher-risk for solar keratoses.   
 
 
NEW ZEALAND 
 
 
New Zealand has not published widely regarding skin cancer screening and education 
(Koh et al., Cancer 1995).  However, a campaign by the New Zealand Cancer Society 
includes “skin check” days at centers throughout New Zealand.  Between 1988 and 1989, 
over 12,000 people were screened for skin cancer.  One of these centers reported findings 
in the literature.  In this study, three melanomas were found in a screening of 746 
participants (Elwood, 1991).  Another study in New Zealand reviewed the New Zealand 
Cancer Registry from 1995-1999, a mandatory reporting of all cancers in New Zealand.   
The study included people of European descent with melanoma and found 4966 
new cases of melanoma in these years; this statistic represents one of the highest rates of 
melanoma in the world.  The authors also reported an increasing Breslow thickness over 
the 5-year period (p<0.001) as well as a statistically significant greater number of 
melanomas in men than women (p<0.001).  Within the country, the highest rate of 
melanoma was in the north (59.1/100,000) as compared to the south (23.5/100,000) with 
rates age-standardized (Martin and Robinson, 2004).   
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AUSTRALIA 
 
 
An article by Marks published in 1999 summarized the public health effort in Australia to 
curtail skin cancer in its population.  With a national survey of nonmelanoma skin cancer 
in 1985, it was found that two out of every three people born in Australia would need 
treatment for at least one skin cancer in their lives (Giles et al., 1988).  Furthermore, 
melanoma mortality rates had been rising through the late 1980’s (Marks et al., 1993), 
but cohort analysis has shown a leveling off and even reduction of mortality rates from 
melanoma recently (Giles et al., 1996).  Early detection and skin cancer prevention have 
been the primary public health objectives in Australia.   
 Starting in the 1970s, an education program was launched in Australia, initially in 
Queensland then more nationally.  Public education campaigns about prevention and 
recognition of skin cancer were the primary goal, with an additional component of 
physician skin cancer education.  This educational information was expanded in 1985, 
when the Australasian Cancer Society and the Australasian College of Dermatologists 
developed the Skin Cancer Awareness Week.  The mainstay of this week was the 
distribution of pamphlets and media regarding the visual aspects of skin cancer, 
distributed to the public as well as every general practitioner in Australia. 
 Part of this campaign was a screening effort for skin cancer.  They developed 
“battle stations” in public venues, including beaches.  This was not considered as a 
national screening effort, but the focus was primarily on education.  However, if a 
screenee had a suspicious lesion, it was recommended that they seek care from a 
physician.  Australia has not instituted a formal skin cancer screening program, because it 
is not felt that the evidence of benefit would justify the cost (Marks, 1999).   
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 Indeed, education is the primary focus of skin cancer prevention in Australia.  A 
nationally televised program about a young man dying from melanoma was aired in three 
parts called “Goodbye Sunshine.”  Because of this program, it was estimated that an 
additional 750 melanomas were diagnosed in the country.  Furthermore, in Victoria, there 
was a 140% increase in melanoma pathology reports than in the year prior to the 
television airing.  These melanomas were also thinner, with an average Breslow depth of 
0.6 mm after the program, compared to 1.6 mm the year before (Theobald et al., 1991).  
One could conclude that education was helpful in increasing diagnosis of melanoma, and 
perhaps encouraging earlier diagnosis.  It may only be a “short term” increase, however, 
as occurred in a similar campaign in Austria. 
 Another study followed a population in Queensland for 10 years prospectively for 
nonmelanoma skin cancer.  Newly diagnosed and treated lesions were recorded, and the 
study was supplemented with visual skin examination.  The authors found that with basal 
cell carcinoma, incidence rates varied according to method of skin cancer surveillance.  
In fact, basal cell cancer incident rates nearly tripled as compared to background 
treatment rates.  It was determined that new basal cell cancers were found on areas other 
than the head, neck, arms and hands, and thus were usually uncovered during full visual 
examinations.  The visual skin examination did not seem to increase incidence on the 
head, neck, arms or hands, as the incidence rates of basal cell in these areas returned to 
baseline after visual screening campaigns.  The authors concluded that there is an 
increased reporting of basal cell carcinomas when a full-body visual examination is 
completed, increasing the apparent burden of cancer on a population (Valery et al., 2004). 
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 Finally, The Lancet published an article in its oncology section titled, “Australian 
charities call for government reinvestment in screening,” referring to skin cancer 
screening.  The article reviewed the latest harrowing epidemiological statistics of skin 
cancer gathered in 1996, the most recent data.  Among Australians older than 14, 374,000 
people had treatment for nonmelanoma skin cancer in 2002, compared to 270,000 in 
1995 and 168,000 in 1985.  Age-standardized incidences for basal cell cancer in women 
is 745/100,000 and in men, 1041/100,000.  Squamous cell cancer incidence for women is 
291/100,000 and 499/100,000 for men.  These data are drastically higher than incidences 
in the United States.  Even the author of the report, Margaret Staples of the National 
Cancer Control Initiative, was “surprised” that the incidence rates of squamous cell 
cancer had tripled in south Australia. 
The article continued to call for a national effort in Australia for screening, 
primarily because the rise of skin cancer is mostly in Australians over age 50.  Although 
it has been reported that these people are beyond the education and primary prevention 
scope of skin cancer, it is believed that nationally organized screening for this population 
(secondary prevention) would actually save costs from a public health perspective.  In 
1996, the government in Australia spent $300,000,000 Australian to treat skin cancer.  A 
national campaign for screening would cost $2,530,000 Australian per year and save the 
healthcare system about $37,000,000 Australian annually (Pincock, 2004).  The authors 
hope that the Australian government will take this into account in determining the cost-
effectiveness of skin cancer screening. 
While this country has higher incidence rates than the United States, the world 
will continue to monitor the state of skin cancer in Australia.  Whether the country 
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institutes a national skin cancer screening program or not, lessons will be learned either 
way in both epidemiology and prevention.  Ideally the correct pathway will become clear 
(to screen or not to screen), and the morbidity and mortality of melanoma and 
nonmelanoma skin cancer will be curtailed.  Perhaps with further research there will be a 
global consensus on skin cancer screening.   
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SKIN CANCER SCREENING IN THE WORKPLACE 
 
 
Both in the United States and internationally, analyses of the relation of occupation to 
cancer, including skin cancer, have been published.  While it is well known that 
ultraviolet radiation is associated with increased risk of squamous cell carcinoma and 
basal cell carcinoma, the risk factors for melanoma are less well-defined.  This chapter 
will review occupational relation to skin cancer risk, as well as a few published skin 
cancer screening efforts in occupational medicine clinics.  It is with great hope that 
gathering this information will further the effort to target high-risk populations 
(particularly men over aged 50, skin types I and II, intermittent sun exposure, 
occupational exposures) for skin cancer screening, particularly in occupational medicine 
clinics.   
 Unna may have made the earliest notation that excessive exposure to the sun was 
related to skin cancer.  He wrote of the changes in sailors’ skin, including skin cancer 
(Unna, 1896).  Sunlight, particularly the ultraviolet range, is carcinogenic.  It is thought 
that UVB (290-320nm) is especially carcinogenic, though UVA (320-400nm) may play a 
role in carcinogenesis as well (deGruijl and Forbes, 1995).  UV radiation is also an 
immunosuppressant in the skin, not only inducing tumors but also decreasing the normal 
immune response to these tumor cells, making it a potent carcinogen (Marks, 1996).   
The most obvious workers exposed to UV radiation are those who work outside.  
A study in England and Wales from 1970-1975 demonstrated an excess number of 
squamous and basal cell carcinomas in outdoor workers (Beral and Robinson, 1981).  A 
more recent study in Japan supported the association between outdoor work and 
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increased risk of actinic keratosis, with an odds ratio of 2.30 (Nagano et al., 1999), yet a 
study in England did not find such an association (Memon et al., 2000).  These 
hyperkeratotic lesions (actinic keratoses) are thought to be precursors to squamous cell 
carcinoma; one study placed the risk of malignant transformation at 1 in 1000 per year 
(Marks et al., 1988).  In any case, these lesions are visual indicators of sun damage. 
 Farmers tend to have an increased risk of skin cancer in several studies.  Multiple 
papers indicate excess mortality of farmers from nonmelanoma skin cancer (Burmeister, 
1981; Decoufle et al., 1977; Whitaker et al., 1979; Milham, 1983).  Particularly, 
squamous cell cancer of the lip is elevated among farmers (Lindquist, 1979).  In a study 
by Keller analyzing discharge diagnoses of patients from Veteran’s Association hospitals 
in the United States, 27% of the lip cancer patients were farmers, whereas only 8% of all 
discharged patients were farmers (1970).  In addition to farmer mortality data, morbidity 
data exists as well (Blair et al., 1985).  In an analysis of chronic disease among farmers in 
the United States, there was an elevation of crude prevalence rates of skin cancer in this 
population (Brackbill et al., 1994).  There was a strong association of farming and 
squamous cell carcinoma in a morbidity study performed in England (Whitaker et al., 
1979) as well as an association with basal cell carcinoma in a risk factor study in Canada 
(Hogan et al., 1989). 
Despite multiple studies implicating sunlight in nonmelanoma skin cancer, 
multiple studies have not found an association between nonmelanoma skin cancer and 
outdoor work.  A study in Denmark failed to find in increased risk of nonmelanoma skin 
cancer and outdoor work, particularly fishing, forestry and agriculture (Olsen and Jensen, 
1987).  Furthermore, a study in Finland actually showed a lower incidence of basal cell 
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cancer in outdoor workers such as farmers, forestry workers and fisherman, whereas 
those in the medical field had a higher incidence (Hannuksela-Svahn et al., 1999).  
Authors of a case-control study in the United Kingdom similarly did not find a 
statistically significant association of occupation to basal cell carcinoma.  Instead, they 
postulated that genetic determinations, such as eye color, hair color and skin color play a 
larger role in determining response to ultraviolet radiation (Lear et al., 1997). 
Green et al. published a paper supporting self-selection in outdoor workers.  
Although people with type I and II skin were represented in greater than 80% of their 
study sample, this population was greatly underrepresented in the outdoor working 
population.  The authors suggested that this self-selection bias with regard to long-term 
outdoor workers may partly explain studies failure to find a statistically significant 
correlation between sun exposure and skin cancer (Green et al., 1996).  In addition, lack 
of power, study design, and uncontrolled or quantified sunlight exposure may also 
contribute to varying study findings. 
Exposures to ultraviolet light other than sunlight occur in various occupations.  
For example, germicidal lamps emit light at approximately 254 nm.  This potentially 
places microbiology laboratory workers, healthcare workers, and any barbers or service 
workers using such antimicrobial lamps at risk for exposure.  Furthermore, welding arcs 
emit light below 290 nm, thus welders, foremen, maintenance workers, metal cutters and 
pipeline workers could be occupationally exposed to ultraviolet light.  Other sources of 
ultraviolet light in the occupational setting include ultraviolet lasers, curing process 
(irradiation and wood curing), printing process, drying and curing paint, dental lights, and 
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metal casting testing (Emmett, 1975).  A summary expanded from Emmett, 1975 can be 
found in Table 9. 
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Table 9: Occupational Exposure to Ultraviolet Radiation 
Potential Source Occupations at Risk 
Outdoor Sun Exposure Agricultural workers, gardeners, 
construction workers, crossing guards, 
window washers, sailors, fishermen, 
lifeguards, professional outdoor athletes, 
railroad track workers, marina workers, 
drivers, pipeline workers, oilfield workers, 
ranchers, roofers, postal carriers, forest 
rangers, police officers, automobile 
salespersons, active duty military in 
combat arms roles, Naval shipmen 
Welding Arc Exposure Welders, foremen, maintenance workers, 
pipeline workers, metal cutters, metal 
workers, shipbuilding, automobile 
manufacturing and repair, aerospace 
manufacturing, building construction, 
bridge construction, power plant and  
refinery repair and construction 
Germicidal Exposure Medical profession, nurses, hospital 
technicians, bacteriology laboratory 
workers, barbers, hairstylists, manicurists 
Plasma Torch Exposure Plasma torch operators working on steel 
joints, HVAC ducts, electrical enclosures, 
metal roofing, siding, and metal cutting 
jobs 
Ultraviolet Laser Exposure Circuit board repair, electronic 
manufacturing, laboratory workers 
Curing Processes Food irradiators, wood curers, adhesive 
bonding in medical and dental industry 
(dental hygienists, dental technicians, 
dentists), finishers of inks (for letterpress, 
lithographic, gravure and screen printing) 
and adhesives (for film, foil or paper 
substrates) in various industries 
Printing Processes Lithographers, screen transferers, printers, 
publishers, ceramics, packaging workers  
Nondestructive Testing Metal casting inspectors, inspectors of 
welding of evaluation of metal structures 
such as tanks, bridges, power plants, 
refineries, pipelines, and petrochemical 
processing facilities 
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Occupational causes of skin cancer other than ultraviolet radiation are of concern.  
In fact, some chemicals may augment the carcinogenesis of ultraviolet light (Emmett, 
1975).  Polycyclic aromatic hydrocarbons are a known occupational exposure associated 
with skin cancer.  In 1775, Sir Percival Pott associated the scrotal cancer noted in 
chimney sweeps with the exposure of the scrotum to soot through pants and the lodging 
in the scrotal rugae (Pott, 1775).  Table 10 outlines specific polycyclic aromatic 
hydrocarbons mentioned by Emmett (1975) and respective occupations at risk for 
exposure.   
 
Table 10: Occupational Exposures Associated with Polycyclic Aromatic 
Hydrocarbons and Skin Cancer  
 
Suspected Agent Occupations at Risk 
Pitch, Tar or Tar Products Tar distilling, Coal gas manufacturing, Pitch 
loading, Briquette manufacturing 
Oil Fractionation and 
Distillation Products 
Shale oil workers, Cotton mule spinners, 
Paraffin wax workers, Mineral cutting oil users, 
refinery workers 
Creosote Timber picklers, Brick title or pipe pressers, 
treated wood product handlers, wood cutters, 
railroad workers, utility pole installers, shingle 
hangers  
Anthracene Chemical workers, particularly producers of 
anthraquinone, dyes, pigments, insecticides, 
wood preservatives and coating materials 
Soot Chimney sweeps, work involving exposure to 
diesel soot  
 
Whitaker et al. found an increased incidence of squamous cell carcinoma in 
English textile spinners (1979); this may be due to exposure to polycyclic aromatic 
hydrocarbons.  Additionally, a significant increase of squamous cell carcinoma of the arm 
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was demonstrated in chemical workers, fishermen and paper/printing workers in this 
same study (Whitaker et al., 1979), though it is unknown what chemicals were involved.   
 Inorganic arsenic is also an occupational (and environmental) carcinogen known 
to cause skin cancer.  Routes of entry are actually not skin contact, rather, they include 
ingestion, inhalation and injection (Emmett, 1975).  Sources today include potassium 
arsenite in Fowler’s solution, arsenic in drinking water (Tseng et al., 1968), metals and 
pesticides.  In 1973 it was estimated by NIOSH that 1.5 million workers were exposed to 
inorganic arsenic at work (US Department of Health, Education and Welfare, 1973), 
though skin cancers due to exposure are rare in the United States (Emmett, 1975).   
 Causes of melanoma are not as clear as those for nonmelanoma skin cancer.  
Strong associations between intermittent sun exposure and development of melanoma are 
becoming more evident in the literature, whereas melanoma’s relationships to lifetime 
sun exposure as well as occupational exposure are less clear (Elwood, 1996).  The focus 
here will be upon various studies analyzing occupational risk (or lack thereof) of 
melanoma, and any higher-risk occupations.  However, an occupation’s relation to sun 
exposure becomes more complicated when vague classifications of sun exposure or 
relation to occupation are used in studies.  This also makes for a difficult comparison 
between studies.   
 Studies have analyzed multiple factors in an effort to elucidate occupational links 
to melanoma.  Multiple studies have found no significant association between outdoor 
work and melanoma (Bataille et al., 2004; Pion et al., 1995; Goodman et al., 1995; Lee 
and Strickland, 1979; Garland et al., 1990).  A few studies have found a protective effect 
of outdoor work on the development of melanoma (Westerdahl et al., 1994; Holman et 
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al., 1986; Osterlind et al., 1988), while another published an increased association 
(Zanetti et al., 1988).  Elwood argues that the definition of outdoor work is quite 
subjective in these studies, and varies greatly from study to study, making comparison 
and conclusion difficult.  He does believe, however, that a large European study 
performed by Autier et al. in 1994 provides a useful definition for outdoor work (1996).  
In this study, outdoor work was defined as having spent at least 30 years or more in an 
outdoor occupation.  After adjusting for host factors, this large study found a significant 
decrease of risk for melanoma (Autier et al., 1994). 
 It may be that intermittent sun exposure is a more important risk factor for 
melanoma than outdoor work (Elwood, 1996).  In fact, multiple studies have found that 
indoor workers are at an increased risk for melanoma as compared to outdoor workers 
(Beral and Robinson, 1981; Lee and Strickland, 1980; Garland et al., 1990).  Beral and 
Robinson reported an excess of melanomas on the trunk and limbs of indoor workers 
(1981).  Many studies have suggested that indoor work is associated with a higher level 
of education, and these “white collar” workers are at an increased risk for melanoma due 
to lifestyle or some other unseen factor (Goodman et al., 1995).  
In fact, Lee and Strickland found that socioeconomic status was the primary 
stratifying factor in melanoma risk in their study, and there was no difference in risk for 
melanoma when comparing indoor versus outdoor workers of similar socioeconomic 
status (1980).  Pion et al. agree to some extent, finding an increased risk for malignant 
melanoma among white collar employees as compared to blue collar employees, and 
higher-income employees had a higher risk of melanoma than lower-income employees 
(1995).   
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Similarly, Vagero et al. found that professionals had the highest risk of melanoma 
in their study, correlating these professionals by a high level of education (1990).  It is 
unlikely that the education itself is a risk factor for melanoma, rather, some common 
lifestyle or environmental factor associated with a high level of education is potentially 
one of the (perhaps many) factors contributing to the higher risk for melanoma in this 
population. 
 Both ionizing and other non-ionizing radiation sources have been linked to 
melanoma.  Workers exposed to artificial UV sources (dentists, physiotherapists and 
lithographers) had an increased risk of melanoma in a study by Perez-Gomez et al.(2004).  
Occupational exposure to x-rays significantly raised the risk of melanoma in one study 
(Pion et al., 1995).  Although rare, radiation can cause malignant melanoma as well 
(Emmett, 1975).  Interestingly, flight crews, including pilots, navigators and flight 
attendants, have repeatedly had an increased risk of melanoma in studies (Vagero et al., 
1990; Gundestrup and Storm, 1999; Rafnsson et al., 2000; Haldorsen et al., 2000).   
Ultraviolet radiation has been discounted as a risk factor, as the dose on the flight 
deck is negligible (Diffey and Roscoe, 1990).  Although travel to sunny destinations is a 
possible lifestyle risk, radiation from flight is also a possibility, as dose increases with 
flight length (Gundestrup and Storm, 1999; Rafnsson et al., 2000).  Occupational 
exposure to magnetic fields has also been linked to malignant melanoma, though the 
authors insist more research should be completed before conclusions are drawn (Tynes et 
al., 2003).   
 Finally, specific occupational exposures are associated with an increased risk of 
malignant melanoma.  Tear gas (α-chloroacetophenone) and polychlorinated biphenyls 
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(PCB’s) have been implicated as possible inducers in the development of malignant 
melanoma (Sober and Fitzpatrick, 1979).  Workers exposed to vinyl chloride and 
polyvinyl chloride had an increased incidence of melanoma in one study (Storetvedt 
Heldaas et al., 1984).  Chemists exposed to benzoyl peroxide, pesticides and plastics 
were found to have an increased risk of malignant melanoma in one study attempting to 
isolate specific occupational exposures increasing risk (Wright et al., 1983).  Increases in 
melanoma have been found among employees in the paper mills and printing industry 
(Linet et al., 1995), but specific chemical exposures have not been elucidated.   
 Although there are multiple risk factors for melanoma (both known and 
unknown), and the working population may be at high-risk for melanoma, few efforts of 
screening in an occupational setting have been published (Greene, 1993).  In the United 
States, several Occupational Safety and Health Administration published standards exist 
that include a visual skin exam in screening and surveillance.  Special emphasis on skin 
exam is included in the following standards: acrylonitrile, inorganic arsenic, 1,3-
butadiene, coke oven emissions, ethylene oxide, formaldehyde (for evidence of irritation, 
not skin cancer), methylenedianiline, methylene chloride, and vinyl chloride (2000).  
Specific OSHA standards and occupational exposures requiring skin examination are 
summarized in Table 11. 
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Table 11: OSHA Standards and Occupational Exposures Requiring Skin 
Examination 
 
Exposure Applicable Standard Skin Examination 
Emphasis 
Acrylonitrile 1910.1045 (n)/1926.1145 Cancer 
Arsenic (Inorganic) 1910.1018(n)/1926.1118 Cancer 
1,3-Butadiene 1910.1051(k)/1926.1151 Cancer 
Coke Oven Emissions 1910.1029(j) Cancer 
Ethylene Oxide 1910.1047(i)/1926.1147 Cancer 
Formaldehyde 1910.1048(l)/1926.1148/1915.1048 Irritation  
Methylenedianiline 1910.1050(m) Cancer 
Methylene Chloride 1910.1052(j)/1926.1152 Cancer 
Vinyl Chloride 1910.1017(k)/1926.1117 Cancer 
 
 To determine the efficacy of occupational medicine practitioners in early 
detection of melanoma, Guibert et al. devised a study in France.  Because the population 
seen by dermatologists as well as general practitioners is a self-selected group to some 
extent, the authors devised a screening process to target a less biased population.  In 
France, all workers aged 18 to 65 years have a screening physical examination.  In 1995 
this population was 25.6 million people, comprising 43.6% of the French population.  
This is a mandatory examination, and the physicians performing the exam are 
“independent in their relations with the persons examined” since there is no doctor-
patient relationship. 
The authors trained the occupational medicine specialists in the ABCDE criteria 
of melanoma (2000).  These criteria were developed by the American Cancer Society and 
used in the educational aspect of this study (A, asymmetry; B, irregular borders; C, 
heterochromous coloration; D, diameter >6 mm; E, enlargement).  The occupational 
 55
medicine physicians in the Nantes region of France were educated for 2 hours on the 
ABCDE criteria, including educational slides.  They were told to refer patients if a lesion 
demonstrated 2 of the 5 ABCDE criteria, or just enlargement alone.  This data was 
recorded and the following year upon annual examination, follow-up was completed.   
In total, 65,000 people were screened during the study.  Of these, 370 had suspect 
lesions and 273 (74%) were seen in follow-up the next year.  For the 101 people who had 
not had interim specialist evaluations, the main reason was negligence (86%).  Among 
the 353 atypical nevi suspected, 78 people had excisions.  In all, there were 5 melanomas 
histologically confirmed.  The melanomas were found in 1 woman and 4 men and had 
Breslow depth of 0.46 to 1.38 mm.  The screenees with melanoma ranged in age from 18 
to 51 years, and all but the woman had realized the lesion was present with range of 3 
months to 12 years (2000). 
The ratio of number of melanomas to number of suspect lesions, 1:70, is similar 
to studies of the pigmented lesion clinics in Britain (1:22- 1:33) and better than the 
United States skin screening ratios (1:250) (MacKie and Hole, 1992; Koh et al. JAAD, 
1996).  The emphasis in this study is that the population screened is working and tends to 
have a “healthy worker effect” which often precludes this population from seeing a 
physician altogether.  This study took advantage of the fact that yearly physical 
examinations offer the optimal time to screen this perhaps underserved population with 
regard to skin cancer screening, and results were quite favorable.  The cost was 
reasonable ($17,000), perhaps due to the use of existing infrastructure (the occupational 
medicine clinic) versus the temporary screening shelters used in other studies (Guibert et 
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al., 2000).  These study results encourage skin cancer screening in the occupational 
medicine setting. 
A discussion of the incurred cost of screening is certainly relevant.  Incorporating 
a skin cancer screening exam into an already scheduled annual surveillance examination, 
pre-employment physical, or workplace injury examination would be minimal in cost.  
Each examination would not be separate from the chief issue for presenting to the clinic; 
rather, it would be incorporated into the pre-existing exam.  A full skin examination 
should take no more than one to two minutes, whereas a partial skin examination would 
take even less time.  There would be no actual additional cost of examination, and 
personal insurance or worker’s compensation would not need to pay specifically for this 
service.  Again, any suspicious lesions would be indicated and referred to an outside 
physician for follow-up.  No actual skin cancer treatment would take place in the 
occupational medicine clinic.  Therefore, insurance and cost would be nonexistent, as the 
skin cancer screening examination would be an adjunct to another already covered visit.  
If an in-house occupational medicine clinic had a plant-wide initiative for skin cancer 
screening, then the cost would be absorbed by the corporation providing the initiative.  
This example, however, would be very unusual, though welcome.   
Other small-scale skin cancer screening efforts in the occupational medicine 
setting have been published.  In a study by Curley et al., indoor workers in an office 
setting of a large British retailer were targeted for skin cancer screening.  In total, they 
screened 2,150 employees and found four melanomas in early stages.  Additionally, three 
other skin cancers were identified, as well as three premalignant lesions (1993).  Another 
study used pre-screening questionnaires to determine whether pre-categorization into risk 
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groups (high, intermediate and low) would help identify screenees at greatest risk.  
Employees at a large hospital were targeted and completed a questionnaire prior to skin 
cancer screening.  Indeed, the high-risk population had a significantly higher percentage 
of suspicious lesions (35%) than did the intermediate group (24%, p<0.001).  The authors 
concluded that such a stratification questionnaire would help to identify the highest-risk 
population at work when performing skin screening exams (Yen et al., 1996). 
While there are a few skin cancer screening studies published, there is little 
research in this area.  The few studies discussed are encouraging, and more research 
needs to be completed in skin cancer screening in the workplace.  Occupational medicine 
clinics are a virtually untapped resource for skin cancer screening in the United States.  
They provide an excellent opportunity to screen workers for skin cancer and prevent 
morbidity and mortality.  The future of skin cancer screening has a potential role for the 
occupational physician, but whether this role will be embraced in the United States is 
uncertain. 
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SKIN CANCER SCREENING IN OCCUPATIONAL MEDICINE 
 
 
Skin cancer screening is a mode of secondary prevention, a natural extension of primary 
prevention.  The worksite is an “ideal setting” for both assessment of cancer risk as well 
as primary prevention (Cornfeld et al., 2002; Eriksen, 1987).  In one assessment of 
worker’s interest in future health programs, the highest interest surpassing other choices 
of nutrition counseling, exercise instruction, stress reduction, breast cancer screening, 
prostate cancer screening, smoking cessation and clinical research was skin cancer 
screening.  In fact, over 82% of people surveyed ranked skin cancer screening of 
moderate or greater interest and this was the highest ranked of all interests available 
(Cornfeld et al., 2002).  Thus, not only is there a desire for skin cancer screening in the 
workplace, but there also is a need.  There is a strong argument for not only primary 
prevention and assessment for cancer risk in the workplace, but also secondary screening 
in the workplace as outlined previously.   
 Skin cancer screening has been proven an effective tool for secondary prevention 
of skin cancer.  There has been some debate over the accuracy of non-dermatologists in 
diagnosing skin cancer, particularly melanoma (Morton and MacKie, 1998).  A thorough 
review of the literature comparing dermatologists’ and primary care physicians’ accuracy 
in diagnosing melanoma was performed by Chen et al.  Reviewed data was inadequate to 
support any differences in diagnostic accuracy of melanoma in a visual skin cancer 
screening exam (2001).  Furthermore, this thesis supports occupational physicians 
screening for skin cancer primarily for the detection rather than the treatment of 
suspicious lesions.  Upon detecting such lesions, appropriate referral is made.  While 
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most occupational physicians will not afford the time for biopsy or treatment of 
suspicious lesions, allotting the time for visual skin cancer screening and referral would 
be more reasonable.  The suggestion is not that the occupational physician rival the 
dermatologist or primary care physician, rather, that the occupational physician work in 
tandem with his or her colleagues. 
It is key to understand that occupational physicians have the opportunity to detect 
skin cancer in a population that one, may not routinely see a physician and two, may be at 
a higher risk than the general population.  First, the “healthy worker effect” may preclude 
many workers from seeing a physician regularly.  Many employees have pre-employment 
physicals, OSHA-mandated physicals, annual physicals, and surveillance exams.  The 
occupational physician will examine these patients as directed, and while the task at hand 
is of greatest importance, it is reasonable to consider skin cancer screening 
simultaneously. 
Second, risk-stratifying patients either with a pre-screening questionnaire or by 
personal, demographic and occupational information will help target patients at risk for 
melanoma and nonmelanoma skin cancer. The highest risk population for melanoma skin 
cancer is men aged 50 years and older (Geller et al. Cancer, 2002).  Indeed, Geller et al. 
call for “outreach to middle-aged and older men,” particularly for melanoma screening.  
Much of the current workforce falls into this demographic and individuals may have 
physical examinations in an occupational medicine setting; these older men are a target 
population for occupational skin cancer screening.  Further, possessing skin types I and II 
and/ or a changing mole increases risk for melanoma, further defining an ideal at-risk 
population for screening (2002).  Additionally, a higher risk for melanoma has been 
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linked to higher education, intermittent sun exposure, and “white-collar” work, and 
patients falling into this risk group (including office workers, administrators) could be 
further targeted.   
Non-melanoma skin cancer is associated with lifetime dose of sunlight or 
ultraviolet radiation, as well as specific exposures outlined in the previous chapter, and 
patients in this risk group (including farmers, agricultural workers, lifeguards) should be 
screened with particular focus on nonmelanoma skin cancer.  Review of specific 
occupational exposures more common in a physician’s patient population linked to 
increased nonmelanoma skin cancer would also help determine patients at higher-risk for 
nonmelanoma skin cancer and therefore important skin cancer screening candidates.  The 
ability of an occupational physician to focus a minute or two of the examination on skin 
cancer screening, even if only on specific members of these defined high-risk populations 
may prevent patient morbidity and mortality.  
Feasibility of skin cancer screening in an occupational medicine setting should be 
investigated further.  However, it is known that full-body skin examinations are accepted 
and welcomed by patients (Federman et al., 2004).  For many of the examinations 
performed by the occupational medicine physician, the patient is often in some state of 
undress or wearing a gown.  This makes skin examination easy and convenient for both 
parties.  Furthermore, skin examination could easily be incorporated into the standard 
examination to decrease effort and time allotted to screening.  For example, an 
examination of the skin on the back after listening to heart sounds or examining the spine 
would be simple and such a targeted approach could apply to the extremities as well.  
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Even simply performing a skin examination on the exposed body parts during an exam 
would be helpful.   
Because the clinical time of an occupational physician (and any physician) is 
valuable, the cost-effectiveness of skin cancer screening must be discussed.  Of the few 
published studies on cost-effectiveness of skin cancer screening, most are supportive of 
screening.  A study by Freedberg and Koh reported that the cost of skin cancer screening 
per year of life saved to be nearly equivalent to other major screening efforts (1990).  In 
1999, Freedberg et al. came to a similar conclusion in another study, this time 
emphasizing high-risk patients.  Yet another study supported this same conclusion, the 
targeting of men over the age of 50 as being a cost-effective population to screen.  
Furthermore, these authors supported the screening by family practitioners, and suggested 
that screening be performed every five years (Girgis et al., 1996).  Occupational medicine 
physicians routinely see this group of patients in their offices, and skin cancer screening 
in this population is likely cost-effective.  These patients would not made a separate visit 
for skin cancer screening, rather, the screening would be an adjunct to the visit, thus 
perhaps costing even less to the health system. 
 If an occupational medicine physician were to begin skin cancer screening 
examinations, either on all patients presenting for examination or only in high-risk 
populations, he or she should improve his or her skin cancer knowledge.  A seminar with 
individual feedback improved primary care physicians’ skills at diagnosing and treating 
skin cancer to the level of dermatologists in a study by Gerbert et al. (1998)  It is likely 
that these results can be generalized to occupational medicine physicians, particularly 
because recognition of suspicious lesions would be emphasized, rather than treatment.  
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Using an internet-based continuing medical education program greatly improved the 
melanoma clinical skills of primary care physicians (Harris et al., 2001).  Since practicing 
physicians must complete a certain amount of CME yearly, this internet-based CME 
would both encourage occupational physicians to use the contents of the lesson as well as 
satisfy professional requirements.  A seminar containing similar content could be 
presented at national or local occupational medicine conferences, thus encouraging 
secondary skin cancer screening by providers. 
 Ideally, efforts to increase skin cancer screening would be most effective if 
supported by large organizations.  It would be best if groups such as the American 
Academy of Dermatology encouraged the American College of Occupational and 
Environmental Medicine (ACOEM) to begin a campaign to increase screening in 
occupational medicine clinics.  Since the AAD has such experience with screening and 
education, a collaborative effort would be effective in disseminating information to 
providers.  This information could be distributed to ACOEM members through the 
organization’s website, and the two groups could even link educational materials.  A 
presentation could be given at the national ACOEM/ American Occupational Health 
Conference encouraging participation. 
Collaboration both between and within organizations would be essential, and 
would likely increase screening efforts in the United States.  Most importantly, a 
population at high-risk (men over age 50, among others) would be reached through a 
public health partnership.  With increased emphasis placed on skin cancer screening by 
ACOEM in cooperation with dermatology associations, it is likely that awareness of skin 
cancer will be raised in the workplace. With education and continued efforts, perhaps 
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management of large corporations will support such screening and encourage the 
workforce to practice primary skin cancer prevention as well.   
Much of the world’s population spends a great percentage of its lifetime at a 
workplace setting.  Multiple risk factors for skin cancer, both nonmelanoma and 
melanoma, have been elucidated.  Many of these risky exposures, including intermittent 
or daily sun, are part of a working environment.  In addition, many of the world’s 
workers are healthy and may not routinely visit physicians.  The occupational medicine 
physician is in a privileged situation regarding both primary and secondary prevention in 
this population.  While the workplace has been utilized as a primary prevention site for 
multiple illnesses and diseases, the opportunity to screen for skin cancer has not 
previously been considered. 
Although the future of occupational medicine has been debated, seizing 
opportunities to improve worker health and the occupational medicine physician’s worth 
simultaneously would be ideal.  I believe that skin cancer screening in the workplace can 
accomplish both of these ends, and the future of skin cancer screening involves the 
occupational medicine physician
 Country Author Study  Results Results Results Results Conclusions 
Europe- 
Collaboration 
EUROSKIN      Incidence,
morbidity 
and 
Mortality of 
NMSC and 
Melanoma 
Future 
Publication 
United 
Kingdom- 
Swansea 
Holme et al., 
Br J 
Dermatol, 
2001 
Screening 
day with 
follow-up 
832 screened 
(315M, 517F) 
57% >50yo 
882 lesions 
suspicious; 
6 suspected 
melanoma 
9 suspected 
basal cell 
40 lesions 
removed from 31 
people; 3 
melanomas  
1 melanoma in 
277 screenees 
Population was higher-risk and better 
yield 
United 
Kingdom 
Herd et al., 
1995; 
Kirkpatrick 
et al., 1995; 
Grover et 
al., 1996; 
Holme et al. 
Br J 
Dermatol, 
2001 
Pigmented 
lesion 
clinics 
Melanoma 
incidence 
rates at these 
specialty 
referral 
centers are 1 
in 20 patients 
to 1 in 60 
patients 
   Population at these specialty centers are 
high-risk and pre-screened/referred 
affording the high rates of melanoma 
incidence 
United 
Kingdom-
Scotland 
Doherty and 
Mackie, 
1988; 
Ellman, 
1991 
Public and 
General 
Practitioner 
Educational 
Campaign 
Since 1985 
Patient 
demand for 
specialty 
referral 
increased 
Skin cancer 
mortality rates 
for women 
decreased 
Thinner lesions 
are being 
reported 
 Public education programs may 
decrease mortality rates from skin 
cancer in women, though no decrease 
has been seen in men 
Table 1-A  Summary of International Screening Efforts 
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BCC= Basal Cell Carcinoma 
SCC= Squamous Cell Carcinoma 
NMSC= Nonmelanoma skin cancer 
AK= Actinic Keratoses 
 Country Author Study  Results Results Results Results Conclusions 
Austria Pehamberg
er et al., 
1993 
Public and 
Physician 
Educational 
Campaign in 
1988 
Significant 
reduction in 
mean Breslow 
depth of 
melanoma the 
next year, but 
increase in 
depth in years 
following 
   Educational campaigns may only offer 
short-term benefit.  
Austria Hofmann-
Wellenhof 
et al., 2000 
Skin cancer 
screenings at 
3 large 
recreational 
centers 1998 
344 screened 
(185M, 159F) 
Average age= 
36.1 y 
45 referred for 
follow-up for 
suspicious 
lesions 
Patients were not 
followed further  
72% of 
participants 
preferred the 
outreach 
screening to a 
doctor’s visit 
Sunbathing population was receptive to 
screening due to already being in a 
state of partial undress.  This suggests 
more innovative community outreach 
screening could reach otherwise 
resistant population. 
Belgium  Vandaele et
al., 2000 
 “Melanoma 
Monday” 
Screening 
and 
educational 
campaign 
1999 
2767 screened 
(almost 2/3 F) 
Average age= 
35yo 
644 suspect 
lesions with 35 
suspected 
melanoma, 59 
suspected 
BCC 
25 melanomas 
confirmed from 
Melanoma 
Monday referral; 
an additional 141 
melanomas 
found in the 
following month 
 Public educational campaign likely 
increased melanoma awareness and 
increased diagnosis of melanoma (in 
the short-term).   
Switzerland  Buillard et
al., 1992 
Public 
health 
education 
campaign 
1988 and 
1989 
Doubling of 
new melanoma 
diagnoses in the 
2 months 
following the 1st 
campaign 
Subsequent 
decrease in 
cases after the 
surge 
Many newly 
diagnosed 
melanomas were 
in patients <60 y 
 Public educational campaign increased 
short-term diagnosis of melanoma.  In 
Switzerland many of the new 
melanoma cases were in people under 
age 60 (traditionally lower-risk).   
Table 1-A (cont’d) 
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 Country Author Study  Results Results Results Results Conclusions 
Denmark Olsen and
Jensen, 
1987 
 Analyzed 
Danish 
cancer data 
from 1970-
1979 
Melanoma 
accounted for 
2.1% all 
incident cancers 
NMSC 
accounted  for 
12% of all 
malignancies  
  A central cancer reporting databank 
aids in the reporting of cancer 
incidence. 
Netherlands  Rampen et
al., 1991 
Screening 
and 
educational 
campaigns 
1989 
2564 screened 262 had 
suspicious 
lesions; 
103 of these 
were 
suspicious for 
cancer 
53 screenees had 
55 confirmed 
malignancies: 9 
melanomas, 1 
lentigo maligna, 
40 BCC, 5 
Bowen’s disease 
 Having a national healthcare system 
may have encouraged the impressive 
85% follow-up rate of screenees with 
suspicious lesions.   
Netherlands Krol et al., 
1991 
Screening 
and 
educational 
campaign at 
beach 
3069 screened 65 had 
suspicious 
lesions 
6 melanomas 
confirmed  
(all < 1 mm 
Breslow depth) 
 Screening at a beach area may be 
acceptable due to partial state of 
undress.  This study found thin 
melanomas.   
Italy Cristofolin
i et al., 
1993 
Educational 
campaign, 
1977 and 
1981 
Analyzed death 
certificates to 
determine 
mortality rates 
of targeted area 
and untargeted 
area (control)  
from melanoma 
before and after 
the campaigns  
Targeted area 
had 
significantly 
less mortality 
from 
melanoma in 
the months 
following the 
campaign 
compared to 
control areas  
  Education may decrease mortality from 
melanoma, perhaps by increased 
awareness and screening.  Whether this 
decrease is only short-term (and 
mortality is merely delayed) is not yet 
known.   
Table 1-A (cont’d) 
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Country Author Study  Results Results Results Results Conclusions 
Canada Engelberg
et al., 
1999 
 Screening 
clinics in 
1994 to 1995 
520 people 
screened 
(218 M, 302 F) 
Average age= 
39yo 
105 people had 
177 suspicious 
lesions 
One melanoma, 
3 BCC and 4 
atypical nevi 
were confirmed, 
2 SCC were 
clinically agreed 
upon 
Only half of 
the screenees 
were older than 
40 years, but 
they comprised 
66% of those 
referred.  One 
in 4 screenees 
over 65 years 
was referred.  
This study reinforces the need to target 
a high-risk population.  In this case, 
higher-risk was associated with older 
age.    
Brazil  Passos da
Rocha et 
al., 2002 
 Cross-
sectional 
population-
based study 
to estimate 
prevalence of 
pre-malignant 
& malignant 
skin lesions 
& sensitivity 
and 
specificity of 
skin cancer 
screening 
1292 
interviewed at 
2112 homes 
All participants 
were >49 y.   
Prevalence of 
premalignant 
and malignant 
lesions 20.7% 
Screening 
Sensitivity= 
20.1% 
Specificity= 
86.7% 
PPV= 29% 
NPV= 80.4% 
  This population had a high prevalence 
of pre-malignant and malignant skin 
lesions.  Targeting an older age 
population (50 years and older) 
provided higher-risk statistics of skin 
lesions.  Brazil is close to the equator 
and the population may have protective 
skin types III or IV and therefore this 
study may not be generalizable.    
Japan  Naruse et
al., 1997; 
Suzuki et 
al., 1997 
 Screening 
effort in 
Kasai City 
(central) to 
determine 
actinic 
keratosis 
prevalence 
1993 
4736 screened 
 
36 AK 
diagnosed 
2 BCC 
0 Melanoma 
Prevalence rate 
of 414 AK per 
100,000 people 
in this region 
 Actinic keratosis prevalence rates were 
estimated for this centrally located city. 
Skin types III or IV are more prevalent 
in this population and may be 
protective for melanoma (none were 
found).   
BCC= Basal Cell Carcinoma 
SCC= Squamous Cell Carcinoma 
NMSC= Nonmelanoma skin cancer 
AK= Actinic Keratoses 
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Country Author Study  Results Results Results Conclusions 
Japan Nagano et
al., 1999 
  Ie Island 
(south) skin 
cancer 
screening 
1993-1996 
1690 screened 
(717M, 973F) 
86 AK 
9 BCC 
2 SCC 
0 Melanoma 
Prevalence rate 
of 573 to 1159 
AK per 100,000 
people in this 
region from 
1993-1996 with 
statistically 
significant OR 
difference 
(compared to 
Kasai City) 1.38-
2.79 
Increased UV radiation was associated with increased 
actinic keratosis prevalence in Japan.   
New 
Zealand 
Martin 
and 
Robinson, 
2004 
Review of the 
NZ cancer 
registry 
1995-1999 
4966 new cases 
of melanoma 
years 1995-
1999 
Increasing 
Breslow 
thickness over 
the years 
 
Greater number 
of melanomas in 
males than 
females 
In this population of northern European descent, there 
exists one of the highest rates of melanoma in the world.  
Again, males seem to be higher-risk for melanoma than 
females.  Increasing Breslow depth in the study is 
concerning for morbidity and mortality.  Future follow-up 
studies would be helpful. 
Australia Theobold
et al., 
1991 
 Educational 
campaign 
“Goodbye 
Sunshine” 
with analysis 
of cancer data 
Estimated  750 
additional 
melanomas 
were diagnosed 
in Australia due 
to the campaign 
140% increase 
in melanoma 
pathology 
reports in 
Victoria 
during the year 
after campaign 
Thinner 
melanomas were 
reported- 
average 0.6 mm 
Breslow depth 
after the 
campaign 
compared to 1.6 
mm before the 
campaign 
Education may be helpful in increasing diagnosis of 
melanoma, perhaps encouraging earlier diagnosis and 
thinner lesions. 
This may be a short-term effect, however, as was seen in 
Austria.   
Table 1-A (cont’d) 
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Table 1-A (cont’d) 
Country Author Study  Results Results Conclusions 
Australia Pincock,
2004 
 Analysis of 
national 
cancer data 
and call for 
skin cancer 
screening 
In people >14y: 
374,000 people 
had treatment 
for NMSC skin 
cancer in 2002, 
compared to 
270,000 in 1995 
and 168,000 in 
1985.   
Age-standardized 
incidence:  
 
FEMALES: 
745 BCC per 100,000  
291 SCC per 100,000 
 
MALES: 
1041 BCC per 100,000  
499 SCC per 100,000 
The article called for a national skin cancer screening effort 
in Australia because the rise of skin cancer is mostly in 
Australians over age 50.  It is believed that nationally 
organized screening for this population (secondary 
prevention) would actually save costs from a public health 
perspective.  In 1996, the government in Australia spent 
$300,000,000 Australian to treat skin cancer.  A national 
campaign for screening would cost $2,530,000 Australian 
per year and save the healthcare system about $37,000,000 
Australian annually. 
BCC= Basal Cell Carcinoma 
SCC= Squamous Cell Carcinoma 
NMSC= Nonmelanoma skin cancer 
AK= Actinic Keratoses 
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